Skip to main content
Log in

Hydroxychloroquine-related psychiatric disorders in COVID-19 patients

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Garcia P, et al. Psychiatric Disorders and Hydroxychloroquine for Coronavirus Disease 2019 (COVID-19): A VigiBase Study. Drug Safety : 19 Oct 2020. Available from: URL: https://doi.org/10.1007/s40264-020-01013-3

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hydroxychloroquine-related psychiatric disorders in COVID-19 patients. Reactions Weekly 1828, 9 (2020). https://doi.org/10.1007/s40278-020-85085-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-020-85085-y

Navigation